MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$68,757
Net Income
-$1,606,653
Net Profit Margin
-2336.71%
EPS
-$0.09
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
68,757
67,864
94,360
84,246
Cost of revenues
10,437
8,218
8,511
2,359
Cost of revenues - related party
14,105
30,645
38,374
30,988
Gross profit
44,215
29,001
47,475
50,899
General and administrative expenses
256,095
1,054,122
657,190
311,379
Salary and benefits
427,298
346,860
-449,310
542,420
Advertising and marketing
301,445
94,073
177,919
104,914
Investor relations
-
12,451
2,887
33,319
Stock based compensation
92,417
1,647,821
26,528
6,601,793
Total operating expenses
1,077,255
3,155,327
415,214
7,593,825
Loss from operations
-1,033,040
-3,126,326
-367,739
-7,542,926
Interest expense
-
-
19,663
75,850
Interest expense - amortization of intangible assets
-
276,815
280,659.75*
-
Impairment of license agreement
-
-
309,985.5*
-
Loss from settlement
-
-
-31,406*
-
Gain from debt extinguishment - related parties
-
-
-1,759,916.75*
-
Interest expense - amortization of intangible assets
279,891
-
-
-
Total other expense
-279,891
-276,815
-2,401,631
-75,850
Loss before income taxes
-1,312,931
-3,403,141
-2,769,370
-7,618,776
Net loss
-1,312,931
-3,403,141
-2,769,370
-7,618,776
Net income (gain) attributed to non-controlling interest
-278
9
197
-558
Net loss attributed to mangoceuticals, inc
-1,312,653
-3,403,150
-2,769,567
-7,618,218
Preferred stock dividend requirements
294,000
294,000
882,000
294,000
Net gain attributed to mangoceuticals, inc. common stockholders
-1,606,653
-3,697,150
-3,651,567
-7,912,218
Basic EPS
-0.09
-0.22
-0.363
-0.69
Diluted EPS
-0.09
-0.22
-0.363
-0.69
Basic Average Shares
17,119,619
16,481,607
10,071,609*
11,524,275
Diluted Average Shares
17,119,619
16,481,607
10,071,609*
11,524,275
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain attributed
to...
-$1,606,653
Net loss attributed
to...
-$1,312,653
(75.76%↑ Y/Y)
Preferred stock dividend
requirements
$294,000
Net income (gain)
attributed to...
-$278
(-13800.00%↓ Y/Y)
Net loss
-$1,312,931
(75.76%↑ Y/Y)
Loss before income
taxes
-$1,312,931
(75.76%↑ Y/Y)
Revenues
$68,757
(-59.10%↓ Y/Y)
Loss from operations
-$1,033,040
(80.39%↑ Y/Y)
Total other expense
-$279,891
(-89.98%↓ Y/Y)
Gross profit
$44,215
(-50.84%↓ Y/Y)
Cost of revenues -
related party
$14,105
(-76.23%↓ Y/Y)
Cost of revenues
$10,437
(-44.53%↓ Y/Y)
Total operating
expenses
$1,077,255
(-79.90%↓ Y/Y)
Interest expense -
amortization of intangible...
$279,891
Salary and benefits
$427,298
(-32.00%↓ Y/Y)
Advertising and marketing
$301,445
(16.71%↑ Y/Y)
General and
administrative expenses
$256,095
(-79.44%↓ Y/Y)
Stock based
compensation
$92,417
(-97.04%↓ Y/Y)
Buy us a coffee
MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC. (MGRX)